Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check2 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, reflecting its terminated status. It also records a revision update to version v3.6.0 and removes the earlier revision entry v3.5.5.SummaryDifference0.5%

- Check9 days agoChange DetectedRevision metadata on the study history page updated from v3.5.4 to v3.5.5, signaling a new revision of the record history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedVersion v3.5.4 has been added to the Study Record Versions list. The previous version v3.5.3 has been removed, updating the history to reflect the latest revision.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision v3.5.2 was removed. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.2 is now listed, replacing v3.5.0, indicating a minor version update to the page history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision metadata was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.